^
Association details:
Evidence:
Evidence Level:
Sensitive: D – Preclinical
Source:
Title:

Novel small-molecule inhibitors of the E3 ubiquitin-ligase Hakai

Published date:
05/28/2021
Excerpt:
...in vitro analyses were performed to determine the antitumor activity of novel Hakin-1 analogues by analyzing E-cadherin levels at cell-cell contacts...E-cadherin results showed that at least two new compounds significantly increased E-cadherin expression at the cell junctions to the DMSO vehicle control, improving Hakin-1 efficacy.